Abstract

Waddlia chondrophila, an obligate intracellular bacterium belonging to the Chlamydiales order, is considered as an emerging pathogen. Some clinical studies highlighted a possible role of W. chondrophila in bronchiolitis, pneumonia and miscarriage. This pathogenic potential is further supported by the ability of W. chondrophila to infect and replicate within human pneumocytes, macrophages and endometrial cells. Considering that W. chondrophila might be a causative agent of respiratory tract infection, we developed a mouse model of respiratory tract infection to get insight into the pathogenesis of W. chondrophila. Following intranasal inoculation of 2 x 108 W. chondrophila, mice lost up to 40% of their body weight, and succumbed rapidly from infection with a death rate reaching 50% at day 4 post-inoculation. Bacterial loads, estimated by qPCR, increased from day 0 to day 3 post-infection and decreased thereafter in surviving mice. Bacterial growth was confirmed by detecting dividing bacteria using electron microscopy, and living bacteria were isolated from lungs 14 days post-infection. Immunohistochemistry and histopathology of infected lungs revealed the presence of bacteria associated with pneumonia characterized by an important multifocal inflammation. The high inflammatory score in the lungs was associated with the presence of pro-inflammatory cytokines in both serum and lungs at day 3 post-infection. This animal model supports the role of W. chondrophila as an agent of respiratory tract infection, and will help understanding the pathogenesis of this strict intracellular bacterium.

Highlights

  • Pneumonia is the third deadliest infectious disease worldwide, responsible for more than 3 million deaths per year [1]

  • Death rate did not increase upon inoculation of 4 x 108 bacteria, and no mortality was observed in the mock treated group, suggesting that the lethal dose 50 (LD50) was close to 2 x 108 W. chondrophila in that model

  • Clinical and experimental data suggest a possible role of W. chondrophila in respiratory tract infections [15,16,30]

Read more

Summary

Introduction

Pneumonia is the third deadliest infectious disease worldwide, responsible for more than 3 million deaths per year [1]. Whereas hospital acquired (nosocomial) pneumonia primarily results from Pseudomonas aeruginosa infection, community acquired (CAP) is mainly due to Streptococcus pneumoniae infection. Others bacterial pathogens such as C. pneumoniae [2], Legionella pneumophila [3], and Haemophilus influenzae [4] lead to pneumonia. Despite the availability of standardized diagnostic tools, in at least 50% of the cases of pneumonia the aetiological agent remains unidentified [7,8,9].

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call